Biotech Startups Have the Answers to Major Pharma’s Problems
Pharma isn’t what it utilised to be. Two important corporations lost about 40% of their stocks’ values in the past decade, when the industry shed 300,000 jobs. Some analysts, including former pharmaceutical executive Bernard Munos, believe additional jobs want to be lost. Munos, now an analyst, thinks pharma has as well much effort in research.
